To date, the enhanced CD163 expression on alveolar/circulating M2 in ILD such as idiopathic pulmonary fibrosis (IPF) and systemic sclerosis has been demonstrated, respectively [44, 45]. The gene discussed is CD163; the disease is idiopathic pulmonary fibrosis.